A systematic review and meta-analysis of the clinimetric properties of the core outcome measurement instruments for clinical effectiveness trials of nutritional and metabolic interventions in critical illness (CONCISE)

Author:

Davies Thomas W1,Kelly Eileen1,Gassel Rob JJ van2,de Poll Marcel van2,Gunst Jan3,Casaer Michael P3,Christopher Kenneth B4,Preiser Jean Charles5,Hill Aileen6,Gundogan Kursat7,Reintam-Blaser Annika8,Rousseau Anne-Françoise9,Hodgson Carol10,Needham Dale M11,Schaller Stefan J12,McClelland Thomas1,Pilkington Joshua J13,Sevin Carla M14,Wischmeyer Paul E15,Lee Zheng Yii16,Govil Deepak17,Chapple Lee-anne18,Denehy Linda19,Montejo-González Juan Carlos20,Taylor Beth21,Bear Danielle E22,Pearse Rupert M1,McNelly Angela1,Prowle John1,Puthucheary Zudin A1

Affiliation:

1. Queen Mary University of London

2. Maastricht University Medical Centre+

3. KU Leuven

4. Brigham and Women's Hospital

5. Erasme University Hospital, Universite Libre de Bruxelles

6. University Hospital RWTH Aachen

7. Erciyes University School of Medicine

8. Lucerne Cantonal Hospital

9. University Hospital of Liège

10. Monash University

11. Johns Hopkins University

12. Charité - Universitätsmedizin Berlin, Corporate member of Freie Universität Berlin, Humboldt- Universität zu Berlin, Berlin Institute of Health

13. Manchester Metropolitan University

14. Vanderbilt University Medical Center

15. Duke University School of Medicine, DUMC

16. University of Malaya

17. The Medicty

18. The University of Adelaide

19. The University of Melbourne

20. Hospital Universitario 12 de Octubre

21. Barnes-Jewish Hospital

22. Guy´s and St Thomas’ NHS Foundation Trust

Abstract

Abstract Background: CONCISE is an internationally agreed minimum set of outcomes for use in nutritional and metabolic clinical research in critically ill adults. Clinicians and researchers need to be aware of the clinimetric properties of these instruments and understand any limitations to ensure valid and reliable research. This systematic review and meta-analysis were undertaken to evaluate the clinimetric properties of the measurement instruments identified in CONCISE. Methods: Four electronic databases were searched from inception to December 2022 (MEDLINE via Ovid, EMBASE via Ovid, CINAHL via Healthcare Databases Advanced Search, CENTRAL via Cochrane). Studies were included if they examined at least one clinimetric property of a CONCISE measurement instrument or recognised variation in adults ≥ 18 years with critical illness or recovering from critical illness in any language. The COnsensus-based Standards for the selection of health Measurement INstruments (COSMIN) checklist for systematic reviews of Patient-Reported Outcome Measures was used. The Preferred Reporting Items for Systematic Reviews and Meta-Analyses were used in line with COSMIN guidance. The COSMIN checklist was used to evaluate the risk of bias and the quality of clinimetric properties. Overall certainty of the evidence was rated using a modified Grading of Recommendations, Assessment, Development and Evaluation approach. Narrative synthesis was performed and where possible, meta-analysis was conducted. Results: A total of 4316 studies were screened. Forty-seven were included in the review, reporting data for 12308 participants. The Short Form-36 Questionnaire (Physical Component Score and Physical Functioning), sit-to-stand test, 6-metre walk test and Barthel Index had the strongest clinimetric properties and certainty of evidence. The Short Physical Performance Battery, Katz Index and handgrip strength had less favourable results. There was limited data for Lawson Instrumental Activities of Daily Living and the Global Leadership Initiative on Malnutrition criteria. The risk of bias ranged from inadequate to very good. The certainty of the evidence ranged from very low to high. Conclusions: Variable evidence exists to support the clinimetric properties of the CONCISE measurement instruments. We recommend using this review alongside CONCISE to guide outcome selection for future trials of nutrition and metabolic interventions in critical illness. Trial registration: PROSPERO (CRD42023438187). Registered 21/06/2023.

Publisher

Research Square Platform LLC

Reference83 articles.

1. Functional disability 5 years after acute respiratory distress syndrome;Herridge MS;N Engl J Med,2011

2. Recovery and outcomes after the acute respiratory distress syndrome (ARDS) in patients and their family caregivers;Herridge MS;Intensive Care Med,2016

3. Needham DM, Davidson J, Cohen H, Hopkins RO, Weinert C, Wunsch H, et al. Improving long-term outcomes after discharge from intensive care unit: report from a stakeholders’ conference. Crit Care Med. 2012;40(2):502–9.

4. Acute Skeletal Muscle Wasting in Critical Illness;Puthucheary ZA;JAMA,2013

5. Metabolic phenotype of skeletal muscle in early critical illness;Puthucheary ZA;Thorax,2018

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线,采集、加工和组织学术论文而形成的新型学术文献查询和分析系统,可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容,当前同舟云学术共收录了国内外主流学术期刊6万余种,收集的期刊论文及会议论文总量共计约1.5亿篇,并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询!咨询电话:010-8811{复制后删除}0370

www.globalauthorid.com

TOP

Copyright © 2019-2024 北京同舟云网络信息技术有限公司
京公网安备11010802033243号  京ICP备18003416号-3